Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Pallas Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Pallas Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 322 · Grade C

Pallas Health

Visit Pallas Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 63 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Pallas Health a bad call — it's best for readers comparing branded or compounded care who will verify the billing cycle and full prepaid amount before choosing a plan. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
50
Supply Reliability
95
82
Transparency
90
58
Access Breadth
93
66
Clinical Oversight
92
78
Track Record
88
44
CoreAge RxBrief Score 94 · 63Pallas Health

Price, coverage & the tracker

CoreAge RxPallas Health
Brief Score94/100 (A)63/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$199 every 4 weeks for compounded treatment after $139 first period; annual plan advertises $139/mo average with prepayment

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$299 every 4 weeks for compounded treatment after $179 first period; annual plan advertises $239/mo average with prepayment

CoverageUS only; restrictions by state, confirmed at intakeNationwide — all 50 states + DC
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Pallas Health: Compounded plans renew every four weeks, with lower advertised averages for longer prepaid terms. Confirm the full charge and supply period; a plan labeled annual may cover 48 weeks.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.